Literature DB >> 2579885

A morphological and immunocytochemical study of a distinctive variant of ductal carcinoma in-situ of the breast.

A S Cross, J G Azzopardi, T Krausz, S van Noorden, J M Polak.   

Abstract

Because so-called 'carcinoid' tumour of the breast has proven to be a difficult entity to define, we studied in-situ carcinoma as there were reasons to believe that this might help clarify the complex problems involved. We studied a consecutive series of 30 cases of ductal carcinoma in-situ (DCIS) by light microscopy and silver impregnation methods and identified a relatively common endocrine variant of DCIS. This variant was studied by immunocytochemical and ultrastructural methods, using conventional DCIS as a control. Endocrine DCIS is identified by its organoid pattern, stromal 'inclusions', festooned structure and a distinctive type of polypoid invagination. It is argyrophilic and rich in neuron-specific enolase. Ultrastructurally it contains abundant dense core granules which are impregnated selectively by Grimelius' method. This tumour type frequently contains peptide hormones of the ACTH family. Three of seven cases contained cells reactive for ACTH and corticotropin-like intermediate lobe peptide CLIP or their precursor, pro-opiomelanocortin. A fourth tumour contained neurotensin, recently identified in a variety of endocrine tumours. Argyrophil invasive carcinomas are a much more heterogeneous group of tumours than argyrophil DCIS and only a minority have an endocrine structure comparable to that described here.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2579885     DOI: 10.1111/j.1365-2559.1985.tb02968.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  16 in total

1.  Mixed apocrine/endocrine ductal carcinoma in situ of the breast coexistent with lobular carcinoma in situ.

Authors:  J D Coyne; P A Dervan; L Barr; A D Baildam
Journal:  J Clin Pathol       Date:  2001-01       Impact factor: 3.411

2.  Endocrine variant of ductal carcinoma in situ of breast: ultrastructural and light microscopical study.

Authors:  M T Ashworth; M T Haqqani
Journal:  J Clin Pathol       Date:  1986-12       Impact factor: 3.411

3.  Immunoreactive opioid peptides in human breast cancer.

Authors:  L Scopsi; E Balslev; N Brünner; H S Poulsen; J Andersen; F Rank; L I Larsson
Journal:  Am J Pathol       Date:  1989-02       Impact factor: 4.307

4.  Sex steroid receptor expression in 'carcinoid' tumours of the breast.

Authors:  C A Birsak; P J Janssen; C C van Vroonhoven; J L Peterse; T H van der Kwast
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

5.  "Revertant" mammary solid papillary carcinoma in lymph node metastasis.

Authors:  Gábor Cserni
Journal:  Pathol Oncol Res       Date:  2002       Impact factor: 3.201

6.  Neurotensin/IL-8 pathway orchestrates local inflammatory response and tumor invasion by inducing M2 polarization of Tumor-Associated macrophages and epithelial-mesenchymal transition of hepatocellular carcinoma cells.

Authors:  Pei Xiao; Xinxin Long; Lijie Zhang; Yingnan Ye; Jincheng Guo; Pengpeng Liu; Rui Zhang; Junya Ning; Wenwen Yu; Feng Wei; Jinpu Yu
Journal:  Oncoimmunology       Date:  2018-03-13       Impact factor: 8.110

Review 7.  [Endocrine mucin-producing sweat gland carcinoma. three case reports with a brief review of the literature].

Authors:  A Rütten; T Mentzel; L Requena
Journal:  Pathologe       Date:  2014-09       Impact factor: 1.011

Review 8.  Carcinomas of the breast with endocrine differentiation: a review.

Authors:  H M Maluf; F C Koerner
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

Review 9.  Working formulation of neuroendocrine tumors of the skin and breast.

Authors:  Sofia Asioli; Maria Pia Foschini; Riccardo Masetti; Vincenzo Eusebi
Journal:  Endocr Pathol       Date:  2014-06       Impact factor: 3.943

10.  Chromogranin A and B gene expression in carcinomas of the breast. Correlation of immunocytochemical, immunoblot, and hybridization analyses.

Authors:  A Pagani; M Papotti; H Höfler; R Weiler; H Winkler; G Bussolati
Journal:  Am J Pathol       Date:  1990-02       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.